Julie Madden

883 total citations
14 papers, 502 citations indexed

About

Julie Madden is a scholar working on Molecular Biology, Oncology and Rheumatology. According to data from OpenAlex, Julie Madden has authored 14 papers receiving a total of 502 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Rheumatology. Recurrent topics in Julie Madden's work include HER2/EGFR in Cancer Research (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Julie Madden is often cited by papers focused on HER2/EGFR in Cancer Research (3 papers), Rheumatoid Arthritis Research and Therapies (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). Julie Madden collaborates with scholars based in United Kingdom, United States and South Africa. Julie Madden's co-authors include Julie L. Boerner, Paul Emery, Kelly L. Mueller, Dennis McGonagle, Ai Lyn Tan, Michael McDermott, Karin List, Charlotte Kuperwasser, Dennis McGonagle and Karen Henshaw and has published in prestigious journals such as PLoS ONE, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Julie Madden

14 papers receiving 490 citations

Peers

Julie Madden
Matthew McCourt United Kingdom
Julie Madden
Citations per year, relative to Julie Madden Julie Madden (= 1×) peers Matthew McCourt

Countries citing papers authored by Julie Madden

Since Specialization
Citations

This map shows the geographic impact of Julie Madden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Madden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Madden more than expected).

Fields of papers citing papers by Julie Madden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Madden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Madden. The network helps show where Julie Madden may publish in the future.

Co-authorship network of co-authors of Julie Madden

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Madden. A scholar is included among the top collaborators of Julie Madden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Madden. Julie Madden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Deal, Oscar, Thomas J. Mitchell, Julie Madden, et al.. (2025). Urinary biomarkers improve prediction of AKI in pediatric cardiac surgery. Frontiers in Pediatrics. 13. 1515210–1515210. 1 indexed citations
2.
Bartoli‐Leonard, Francesca, et al.. (2024). Altered Inflammatory State and Mitochondrial Function Identified by Transcriptomics in Paediatric Congenital Heart Patients Prior to Surgical Repair. International Journal of Molecular Sciences. 25(13). 7487–7487. 1 indexed citations
3.
Salamango, Daniel J., et al.. (2018). CUL5 is required for thalidomide-dependent inhibition of cellular proliferation. PLoS ONE. 13(5). e0196760–e0196760. 5 indexed citations
4.
Colacino, Justin A., Ebrahim Azizi, Michael Brooks, et al.. (2018). Heterogeneity of Human Breast Stem and Progenitor Cells as Revealed by Transcriptional Profiling. Stem Cell Reports. 10(5). 1596–1609. 106 indexed citations
5.
Allen, Steven G., Yu‐Chih Chen, Julie Madden, et al.. (2016). Macrophages Enhance Migration in Inflammatory Breast Cancer Cells via RhoC GTPase Signaling. Scientific Reports. 6(1). 39190–39190. 41 indexed citations
6.
Madden, Julie, Kelly L. Mueller, Aliccia Bollig‐Fischer, et al.. (2014). Abrogating phosphorylation of eIF4B is required for EGFR and mTOR inhibitor synergy in triple-negative breast cancer. Breast Cancer Research and Treatment. 147(2). 283–293. 20 indexed citations
7.
Mueller, Kelly L., Katelyn Powell, Julie Madden, Scott T. Eblen, & Julie L. Boerner. (2012). EGFR Tyrosine 845 Phosphorylation-Dependent Proliferation and Transformation of Breast Cancer Cells Require Activation of p38 MAPK. Translational Oncology. 5(5). 327–IN1. 41 indexed citations
10.
Vital, Edward M, Andy C. Rawstron, Shouvik Dass, et al.. (2010). Reduced-dose rituximab in rheumatoid arthritis: Efficacy depends on degree of B cell depletion. Arthritis & Rheumatism. 63(3). 603–608. 65 indexed citations
11.
McGonagle, Dennis, et al.. (2008). Rituximab use in everyday clinical practice as a first-line biologic therapy for the treatment of DMARD-resistant rheumatoid arthritis. Lara D. Veeken. 47(6). 865–867. 29 indexed citations
12.
Madden, Julie. (2008). Managing patients with resistant rheumatoid arthritis. Nursing Standard. 22(43). 51–57. 1 indexed citations
13.
McGonagle, Dennis, Ai Lyn Tan, Julie Madden, Paul Emery, & Michael McDermott. (2008). Successful treatment of resistant pseudogout with anakinra. Arthritis & Rheumatism. 58(2). 631–633. 90 indexed citations
14.
Grimble, Robert F., Peter Andersson, Julie Madden, et al.. (2003). Gene: Gene interactions influence the outcome in elderly patients. Clinical Nutrition. 22. S39–S39. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026